ProPublica

Journalism in the Public Interest

Cancel

Prescriber Checkup

Prescriber Checkup » Vermont » Family Medicine

Top Family Medicine Prescribers in Vermont

Top Prescribers

Providers are grouped by the primary specialty they listed when applying for a national health ID number. This doesn’t necessarily mean the person has special training or certification. Specialty is self-reported by providers and may have changed. Patients and claims shown are for Medicare Part D only.

Prescriber Claims Filled Total Cost Medicare Part D Patients Claims for Brand Name Drugs Schedule Two Schedule Three Dangerous Drugs to Seniors Brand Name Drugs Prescription Price
TERRI NIELSEN MD

Family Medicine

3,789

$226K

252
172 are 65+

6%
patients receiving schedule two controlled substances

Avg: 8%

8%
patients receiving schedule three controlled substances

Avg: 7%

1%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

19%
prescriptions for brand name drugs

Avg: 23%

$60
Average prescription price

Avg: $63

CARRIE WULFMAN MD

Family Medicine

3,786

$216K

242
155 are 65+

12%
patients receiving schedule two controlled substances

Avg: 8%

10%
patients receiving schedule three controlled substances

Avg: 7%

2%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

25%
prescriptions for brand name drugs

Avg: 23%

$57
Average prescription price

Avg: $63

DANA KRAUS MD

Family Medicine

3,755

$275K

184
114 are 65+

17%
patients receiving schedule two controlled substances

Avg: 8%

13%
patients receiving schedule three controlled substances

Avg: 7%

1%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

25%
prescriptions for brand name drugs

Avg: 23%

$73
Average prescription price

Avg: $63

MOSS LINDER M.D.

Family Medicine

3,746

$309K

196
127 are 65+

20%
patients receiving schedule two controlled substances

Avg: 8%

10%
patients receiving schedule three controlled substances

Avg: 7%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

24%
prescriptions for brand name drugs

Avg: 23%

$83
Average prescription price

Avg: $63

DALE STAFFORD M.D.

Family Medicine

3,741

$231K

229
179 are 65+

9%
patients receiving schedule two controlled substances

Avg: 8%

7%
patients receiving schedule three controlled substances

Avg: 7%

1%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

18%
prescriptions for brand name drugs

Avg: 23%

$62
Average prescription price

Avg: $63

SUSAN GRESSER M.D.

Family Medicine

3,699

$165K

230
168 are 65+

0%
patients receiving schedule two controlled substances

Avg: 8%

10%
patients receiving schedule three controlled substances

Avg: 7%

2%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

17%
prescriptions for brand name drugs

Avg: 23%

$45
Average prescription price

Avg: $63

LINDA BISSON MD

Family Medicine

3,669

$275K

284
160 are 65+

11%
patients receiving schedule two controlled substances

Avg: 8%

10%
patients receiving schedule three controlled substances

Avg: 7%

2%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

20%
prescriptions for brand name drugs

Avg: 23%

$75
Average prescription price

Avg: $63

MELISSA VOLANSKY MD

Family Medicine

3,643

$274K

183
124 are 65+

11%
patients receiving schedule two controlled substances

Avg: 8%

9%
patients receiving schedule three controlled substances

Avg: 7%

1%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

26%
prescriptions for brand name drugs

Avg: 23%

$75
Average prescription price

Avg: $63

DIANE RIPPA M.D.

Family Medicine

3,636

$286K

187
155 are 65+

6%
patients receiving schedule two controlled substances

Avg: 8%

0%
patients receiving schedule three controlled substances

Avg: 7%

1%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

25%
prescriptions for brand name drugs

Avg: 23%

$79
Average prescription price

Avg: $63

LISE KOWALSKI M.D.

Family Medicine

3,610

$224K

238
174 are 65+

10%
patients receiving schedule two controlled substances

Avg: 8%

6%
patients receiving schedule three controlled substances

Avg: 7%

1%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

20%
prescriptions for brand name drugs

Avg: 23%

$62
Average prescription price

Avg: $63

CRAIG SULLIVAN MD

Family Medicine

3,609

$199K

250
184 are 65+

11%
patients receiving schedule two controlled substances

Avg: 8%

9%
patients receiving schedule three controlled substances

Avg: 7%

2%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

19%
prescriptions for brand name drugs

Avg: 23%

$55
Average prescription price

Avg: $63

JOHN BROOKLYN M.D.

Family Medicine

3,558

$283K

197
81 are 65+

18%
patients receiving schedule two controlled substances

Avg: 8%

9%
patients receiving schedule three controlled substances

Avg: 7%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

27%
prescriptions for brand name drugs

Avg: 23%

$80
Average prescription price

Avg: $63

MICHAEL GRAHAM MD

Family Medicine

3,445

$216K

254
197 are 65+

7%
patients receiving schedule two controlled substances

Avg: 8%

5%
patients receiving schedule three controlled substances

Avg: 7%

1%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

23%
prescriptions for brand name drugs

Avg: 23%

$63
Average prescription price

Avg: $63

THOMAS EVANS M.D.

Family Medicine

3,411

$215K

183
152 are 65+

11%
patients receiving schedule two controlled substances

Avg: 8%

10%
patients receiving schedule three controlled substances

Avg: 7%

1%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

22%
prescriptions for brand name drugs

Avg: 23%

$63
Average prescription price

Avg: $63

MARTINA SCZESNY-ALESHNICK M.D.

Family Medicine

3,397

$219K

176
149 are 65+

9%
patients receiving schedule two controlled substances

Avg: 8%

11%
patients receiving schedule three controlled substances

Avg: 7%

1%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

25%
prescriptions for brand name drugs

Avg: 23%

$65
Average prescription price

Avg: $63

JOSEPH HADDOCK MD

Family Medicine

3,319

$176K

207
164 are 65+

10%
patients receiving schedule two controlled substances

Avg: 8%

10%
patients receiving schedule three controlled substances

Avg: 7%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

20%
prescriptions for brand name drugs

Avg: 23%

$53
Average prescription price

Avg: $63

MARA VIJUPS M.D.

Family Medicine

3,317

$223K

240
151 are 65+

9%
patients receiving schedule two controlled substances

Avg: 8%

5%
patients receiving schedule three controlled substances

Avg: 7%

1%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

21%
prescriptions for brand name drugs

Avg: 23%

$67
Average prescription price

Avg: $63

KIMBERLY BRUNO MD

Family Medicine

3,317

$218K

208
158 are 65+

7%
patients receiving schedule two controlled substances

Avg: 8%

12%
patients receiving schedule three controlled substances

Avg: 7%

1%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

22%
prescriptions for brand name drugs

Avg: 23%

$66
Average prescription price

Avg: $63

RACHEL DISANTO M.D.

Family Medicine

3,286

$250K

218
164 are 65+

16%
patients receiving schedule two controlled substances

Avg: 8%

8%
patients receiving schedule three controlled substances

Avg: 7%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

22%
prescriptions for brand name drugs

Avg: 23%

$76
Average prescription price

Avg: $63

ROBERT PENNEY MD

Family Medicine

3,224

$202K

145
86 are 65+

13%
patients receiving schedule two controlled substances

Avg: 8%

19%
patients receiving schedule three controlled substances

Avg: 7%

3%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

25%
prescriptions for brand name drugs

Avg: 23%

$63
Average prescription price

Avg: $63

DENISE PAASCHE M.D.

Family Medicine

3,221

$217K

161
124 are 65+

16%
patients receiving schedule two controlled substances

Avg: 8%

9%
patients receiving schedule three controlled substances

Avg: 7%

2%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

21%
prescriptions for brand name drugs

Avg: 23%

$67
Average prescription price

Avg: $63

RICHARD BURGOYNE M.D.

Family Medicine

3,203

$200K

224
162 are 65+

7%
patients receiving schedule two controlled substances

Avg: 8%

8%
patients receiving schedule three controlled substances

Avg: 7%

1%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

19%
prescriptions for brand name drugs

Avg: 23%

$63
Average prescription price

Avg: $63

THOMAS BRODERICK D.O.

Family Medicine

3,176

$188K

354
264 are 65+

16%
patients receiving schedule two controlled substances

Avg: 8%

6%
patients receiving schedule three controlled substances

Avg: 7%

1%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

18%
prescriptions for brand name drugs

Avg: 23%

$59
Average prescription price

Avg: $63

HARLEY DONNELLY MD

Family Medicine

3,152

$173K

244
189 are 65+

10%
patients receiving schedule two controlled substances

Avg: 8%

8%
patients receiving schedule three controlled substances

Avg: 7%

2%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

17%
prescriptions for brand name drugs

Avg: 23%

$55
Average prescription price

Avg: $63

FAY HOMAN M.D.

Family Medicine

3,128

$125K

114
100 are 65+

16%
patients receiving schedule two controlled substances

Avg: 8%

0%
patients receiving schedule three controlled substances

Avg: 7%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

16%
prescriptions for brand name drugs

Avg: 23%

$40
Average prescription price

Avg: $63

Sources

Centers for Medicare and Medicaid Services; National Technical Information Service; First Databank